Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to -$1.6 million.

  • Lifecore Biomedical's Other Working Capital Changes fell 85.52% to -$1.6 million in Q2 2025 from the same period last year, while for May 2025 it was -$378,000, marking a year-over-year increase of 86.76%. This contributed to the annual value of -$378,000 for FY2025, which is 86.76% up from last year.
  • Latest data reveals that Lifecore Biomedical reported Other Working Capital Changes of -$1.6 million as of Q2 2025, which was down 1,763.92% from $97,000 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Other Working Capital Changes registered a high of $2.6 million during Q3 2021, and its lowest value of -$6.6 million during Q2 2021.
  • In the last 3 years, Lifecore Biomedical's Other Working Capital Changes had a median value of $68,000 in 2024 and averaged -$611,300.
  • Per our database at Business Quant, Lifecore Biomedical's Other Working Capital Changes skyrocketed by 290.48% in 2021 and then tumbled by 31,678.57% in 2023.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Other Working Capital Changes stood at -$664,000 in 2021, then surged by 97.89% to -$14,000 in 2022, then plummeted by 31,678.57% to -$4.4 million in 2023, then skyrocketed by 120.79% to $925,000 in 2024, then crashed by 85.52% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q2 2025, $97,000 for Q1 2025, and $925,000 during Q4 2024.